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Over the last years, antimicrobial peptides (AMPs) have been the focus of intense research
toward the ﬁnding of a viable alternative to current antifungal drugs. Defensins are one
of the major families of AMPs and the most represented among all eukaryotic groups,
providing an important ﬁrst line of host defense against pathogenic microorganisms.
Several of these cysteine-stabilized peptides present a relevant effect against fungi.
Defensins are the AMPs with the broader distribution across all eukaryotic kingdoms,
namely, Fungi, Plantae, and Animalia, and were recently shown to have an ancestor
in a bacterial organism. As a part of the host defense, defensins act as an important
vehicle of information between innate and adaptive immune system and have a role in
immunomodulation. This multidimensionality represents a powerful host shield, hard for
microorganisms to overcome using single approach resistance strategies. Pathogenic fungi
resistance to conventional antimycotic drugs is becoming a major problem. Defensins, as
other AMPs, have shown to be an effective alternative to the current antimycotic therapies,
demonstrating potential as novel therapeutic agents or drug leads. In this review, we
summarize the current knowledge on some eukaryotic defensins with antifungal action.
An overview of the main targets in the fungal cell and the mechanism of action of these
AMPs (namely, the selectivity for some fungal membrane components) are presented.
Additionally, recent works on antifungal defensins structure, activity, and cytotoxicity are
also reviewed.
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INTRODUCTION
Naturally occurring antimicrobial peptides (AMPs) probably
represent one of the ﬁrst successful forms of chemical defense
of eukaryotic cells against bacteria, protozoa, fungi, and viruses
(Ganz and Lehrer, 1998; Lehrer and Ganz, 1999; Zasloff, 2002;
Mookherjee and Hancock, 2007; Lai and Gallo, 2009; Guo et al.,
2012; Domingues et al., 2014), being also active against can-
cer cells (Hoskin and Ramamoorthy, 2008; Gaspar et al., 2013).
Currently commercialized antibiotics are mostly of microbial
origin or synthesized from those. These antibiotics are losing
efﬁcacy as a result of high selection pressure, leading to rapid
emergence of resistance in many important human pathogens,
thus threatening to put an end to the golden age of antibiotics
(Clardy et al., 2009; Fisher et al., 2012). The use of antifun-
gal treatments has increased as a consequence of the increase
of immunocompromised patients, mostly due to improvements
in oncology and transplant ﬁelds (Mehra et al., 2012), lead-
ing to more frequent resistances to the drugs used. A strategy
to overcome this problem can be found in AMPs, which are
part of the innate immune system of different living organ-
isms (Hegedus and Marx, 2013), such as plants (Thomma
et al., 2002; Lay and Anderson, 2005; Gonçalves et al., 2012b),
fungi (Mygind et al., 2005; Schneider et al., 2010; Oeemig et al.,
2012), bacteria (Zhu, 2007; Gao et al., 2009), invertebrates (Bulet
and Stocklin, 2005; Ayroza et al., 2012), and vertebrates (Ganz,
2004; Sahl et al., 2005; van Dijk et al., 2008; Gonçalves et al.,
2012a).
Although some AMPs have had their target unveiled, many
are still unclear. Some mechanisms of action of antifungal pep-
tides have been reported, such as binding to the cell wall,
membrane permeabilization, receptor-mediated internalization
inducing signaling cascades, and interaction with intracellular tar-
gets, inducing the formation of reactive oxygen species (ROS),
leading ultimately to apoptosis (Hancock and Rozek, 2002; Ober-
parleiter et al., 2003; Thevissen et al., 2003a, 2004; de Coninck
et al., 2013; van der Weerden et al., 2013). Apoptosis is a type of
programed cell death, which is regulated by a complex network of
proteins and metabolic pathways. The central core of this process
is regulated by a family of proteins named caspases. Yeasts have at
least one ortholog of mammalian caspases: the metacaspase YCA1
(yeast caspase 1; Madeo et al., 2002). Routinely used assays aiming
at the detection of these apoptotic features are used for the identi-
ﬁcation of fungal cells undergoing apoptosis after treatment with
antifungal agents.
Antimicrobial peptides have variable amino acid composition
and size (ranging from less than 10 to more than 100 amino acid
residues), commonly being cationic and amphipathic molecules
(Brogden et al., 1996; Yang et al., 2003; Fontana et al., 2004;
Glaser et al., 2005; Domingues et al., 2014). To date, more than
2200 natural or synthetic AMPs have been identiﬁed, as listed
by the Antimicrobial Peptide Database (APD1), of which over
1900 have antibacterial activity and 800 have antifungal activity.
1http://aps.unmc.edu/AP/main.php
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This discrepancy, however, may be redundant as antibacterial
AMPs may also have antifungal activity, but this property is not
systematically assessed.
Antimicrobial peptides may have linear structures, like indoli-
cidin (Ladokhin et al., 1999), or they may have tertiary struc-
tures stabilized by disulﬁde bonds, with β-sheet (e.g., protegrin;
Aumelas et al., 1996; and the defensin human neutrophil pep-
tide 1, HNP-1; Zhang et al., 2011), α-helix (e.g., dermaseptin;
Mor et al., 1991) or αβ-motif secondary structure (e.g., dro-
somycin; Landon et al., 1997; and Pisum sativum defensin 1, Psd1;
Almeida et al., 2002).
The most studied families of AMPs are cathelicidins, der-
maseptins, magainins, cecropins, and defensins. Cathelicidins
are found in the innate immune system of mammals, amphib-
ians, and reptiles (Wang et al., 2008; Tsai et al., 2011; Hao et al.,
2012); dermaseptins and magainins are found in amphibians
(Morton et al., 2007); cecropins are found in insects (YiZeng
et al., 1989); and defensins, which are the largest family of AMPs,
have also the broader distribution across the majority of eukary-
otic organisms (Wang et al., 2013). Besides having antimicrobial
activity, defensins also have immunomodulatory functions in the
organisms that produce these peptides. Defensins with antifun-
gal properties are present in all eukaryotic kingdoms, pointing
out to a common ancestor. This review is focused on defensins
(as well as some defensin-like peptides) with antifungal activity.
However, it is impossible to describe here all the defensins with
this activity. Therefore, we highlight some of the most recent
research made on this ﬁeld. The chosen peptides are described
taking into consideration their speciﬁc properties, evolution-
ary background, organism of origin, and antifungal mode of
action.
Some databases have been created in order to provide useful
information for the study of AMPs. Among the AMP databases,
PhytAMP is a database dedicated to antimicrobial plant pep-
tides2 (Hammami et al., 2009). This resource contains valuable
information on these AMPs, including peptide sequences, tax-
onomic, microbiological, and physicochemical data. Another
database, Collection of Anti-Microbial Peptides (CAMP3), holds
2http://phytamp.pfba-lab-tun.org/main.php
3http://www.camp.bicnirrh.res.in/
experimentally validated and predicted AMP sequences and
structures of AMPs. These databases include several tools for
AMPs analysis and prediction, helping in the design of new
therapeutic peptides based on speciﬁc structure and functional
features.
DEFENSINS
Defensins are the largest groups of AMPs. These peptides are
cysteine-rich and have diverse sequences and structures, stabilized
into compact shapes by three or four conserved cysteine disulﬁde
bridges. They have at least two positive charges (lysine or argi-
nine residues) and are small, ranging approximately from 12 to 50
amino acid residues (2–6 kDa; Ganz, 2003; Ren et al., 2011; Gao
and Zhu, 2012).
Vertebrates’ defensins are divided into three subfamilies: α-, β-,
and θ-defensins. α-Defensins are present in mammals such as
humans, monkeys, and several rodent species, being particularly
abundant in neutrophils, certain macrophage subpopulations and
Paneth cells of the small intestine (Ouellette and Selsted, 1996;
Ganz and Lehrer, 1998; Lehrer and Ganz, 1999). β-defensins
are found in a wide range of vertebrates, presenting a cysteine-
stabilized αβ-motif composed of an antiparallel β-sheet and an
α-helix. As an example, on bovine neutrophils, as many as 13
β-defensins have been identiﬁed (Yang et al., 2002a). However,
in other species, β-defensins are mostly produced by epithelial
cells lining different organs (e.g., epidermis, bronchial tree, and
genitourinary tract). θ-Defensins, present only inOldWorldmon-
keys, are cyclic and derived from α-defensins (Lehrer, 2004; Lehrer
and Lu, 2011; Semple and Dorin, 2012). In Figure 1, conserved
cysteine residues among defensins from different kingdoms are
shown.
Plants, fungi, and many invertebrates produce defensin-like
peptides structurally similar to the β-defensins from vertebrates
(Thomma et al., 2002; Bulet and Stocklin, 2005; Mygind et al.,
2005; Sahl et al., 2005; Yount and Yeaman, 2006; van Dijk et al.,
2008; Ayroza et al., 2012; Oeemig et al., 2012). These observa-
tions allowed to assume that defensins and defensin-like peptides
all evolved from a common precursor. The relatively recent
identiﬁcation of three defensins in lower eukaryotes, plectasin
from Pseudoplectania nigrella (Mygind et al., 2005), eurocin from
Eurotium amstelodami (Oeemig et al., 2012), and bubble protein
FIGURE 1 | Comparison of amino acid residues sequence of
selected defensins with antifungal activity from animals, plants, and
fungi: human defensin 5 (HD5), Pisum sativum defensin 1 (Psd1),
and Penicillium brevicompactum Dierckx bubble protein (BP),
respectively. Conserved cysteine residues among defensins from
different kingdoms are indicated. The colors used in the sequences
represent basic, non-polar hydrophobic, polar-uncharged and acidic
residues.
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(BP) from Penicillium brevicompactum Dierckx (Seibold et al.,
2011), is important to demonstrate the wide distribution of
these peptides over diverse eukaryotic lineages, which suggests
that ancestral defensin genes existed over 1500 million years
ago, before Fungi, Plantae, and Animalia kingdoms diverged
(Wang et al., 1999). The wide distribution of these peptides in
the Eukarya domain could suggest their uniqueness to eukary-
otic cells, but it was possible to determine that these peptides
may have had their ancestor in a prokaryotic organism after
the discovery of the ﬁrst defensin-like peptide in the bacte-
ria Anaeromyxobacter dehalogenans (AdDLP; Zhu, 2007; Gao
et al., 2009). This defensin-like peptide is proposed as an ances-
tor of eukaryotic defensins and defensin-like peptides due to
the similarity of their structures, namely at the level of the
cysteine-stabilized αβ-motif (Zhu, 2007). These ﬁndings further
support the concept that AMPs may have been fundamental to
the evolutionof multicellular organismswithinmicrobial-exposed
environments.
Although defensins were initially identiﬁed only as AMPs,
recent studies have demonstrated that they have a much broader
range of action, including immunomodulatory function (issue
further developed in the text, in Section “Immunomodulatory
Function”; Ulm et al., 2012).
RECENTLY STUDIED ANTIFUNGAL DEFENSINS
When a new AMP is described, the most usual properties to
assess are structure and peptide sequence, antimicrobial activity,
expressed mainly in terms of minimal inhibitory concentration
(MIC) or half maximal inhibitory concentration (IC50), cytotox-
icity and lytic activity against human cells (whenever the AMP
origin is not mammalian), target, and mode of action toward the
pathogen tested. The following AMPs were classiﬁed as defensins
or defensin-like peptides due to their structural and sequence
homologies with other defensins. They are examples of some of
the recently studied antifungal defensins from fungal, plant, and
animal origin that fulﬁll most of the properties expressed above.
Further details and a list of some of these defensins can be found
in Table 1.
FUNGAL SOURCES
Defensin-like antifungal peptides secreted by ﬁlamentous fungi
have a low molecular mass (5.8–6.6 kDa), a basic char-
acter, presence of 4–10 cysteine residues and several disul-
ﬁde bonds (providing resistance against temperature stress or
adverse solvent conditions), and a β-barrel conformation (Hagen
et al., 2007; Seibold et al., 2011). Proteins with such proper-
ties with antifungal activity have been isolated and investi-
gated from several Ascomycota fungal species, such as Peni-
cillium chrysogenum, Penicillium nalgiovense, Penicillium bre-
vicompactum Dierckx, Aspergillus giganteus, and Aspergillus
niger (Galgóczy et al., 2010; Seibold et al., 2011). Among these
fungus-derived antifungal peptides, the most intensively stud-
ied are Penicillium chrysogenum antifungal protein (PAF) and
Aspergillus giganteus antifungal protein (AFP), with six and
eight cysteines, respectively. Penicillium brevicompactum Dier-
ckx bubble protein structure is considerably similar to PAF and
AFP.
Penicillium chrysogenum antifungal protein
PAF acts through a G protein-coupled signal transduction path-
way, although this mechanism is not entirely understood (Marx
et al., 2008). The G protein-coupled activity of PAF was conﬁrmed
by the study of the fadA mutant of Aspergillus nidulans which
proved to be less sensitive to PAF treatment compared to the
wild-type. The fadA gene encodes the heterotrimeric G protein
α subunit, which dissociation from the Gβγ complex is inhibited
in the fadA mutant Aspergillus nidulans (Leiter et al., 2005). These
results indicate that PAF toxicity requires active heterotrimeric
G protein signaling (Leiter et al., 2005; Marx et al., 2008). Based
on these observations, Marx et al. (2008) hypothesized that PAF
interacts directly or indirectly with G protein signal transduction
pathways. These authors also hypothesized that the cell wall could
be a selective barrier for PAF, but in vivo chitin-binding activity
of PAF has not been demonstrated yet. In the sensitive organ-
isms, PAF exerts multiple detrimental effects: induction of plasma
membrane polarization, increased exposure of phosphatidylserine
(PS) on the cell surface, DNA fragmentation,membrane blebbing,
cell shrinking, intracellular ROS production, and apoptosis-like
phenotype (Kaiserer et al., 2003; Leiter et al., 2005; Marx et al.,
2008).
Aspergillus giganteus antifungal protein
In susceptible organisms, AFP disturbs the polarized growth of
hyphae by interfering directly or indirectly with the cell wall
biosynthesis (Theis et al., 2003). Hagen et al. (2007) demonstrated
that AFP can bind to chitin in vitro, and inhibits the cell wall
chitin biosynthesis by the speciﬁc inhibition of chitin synthase III
andV. These enzymes are unique among fungi and essential for the
maintenance of the polarized growth and virulence of pathogenic
fungi. Presence of chitin synthase III and V is conﬁrmed in the
AFP-sensitive fungi, while the insensitive fungal species do not
have these enzyme classes. Sphingolipid membrane components
in the sensitive fungi might serve as secondary receptors for AFP.
This was further conﬁrmed by the discovery that the depletion
of cellular glucosylceramide (GlcCer) levels in AFP-sensitive fun-
gal species (Aspergillus fumigatus and Aspergillus niger) resulted in
reduced AFP susceptibility (Meyer, 2008). This, together with the
observation that the sphingolipids are necessary to maintain the
polarized hyphal growth, elucidates the mechanism of polarized
growth degeneration effect of AFP (Li et al., 2006; Meyer, 2008).
The species speciﬁcity of AFP may be related with the sphingolipid
proﬁle of the sensitive fungi (Meyer, 2008).
Penicillium brevicompactum Dierckx bubble protein
This fungal defensinwas ﬁrst described in 2003 (Olsen et al., 2004).
It is found in the bright yellow–green ﬂuorescent exudate bubbles
of the ascomycete fungus Penicillium brevicompactum Dierckx.
Similarly to other ascomycetes, BP produces a small antimicro-
bial molecule, mycophenolic acid, which gives the bubbles their
yellow–green ﬂuorescence. This combined production suggests a
possible synergistic action between defensins and other antibiotic
agents produced by this class of fungi (Seibold et al., 2011). BP has
64 amino acid residues, with high content of basic amino acids,
β-barrel conformation (Olsen et al., 2004), and a cage-like pattern
of four very stable disulﬁde bridges. In addition, it was discovered
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that the closely related fungus Penicillium chrysogenum encodes a
BP homolog (in addition to PAF), indicating that fungi may have
more than one defensin (Seibold et al., 2011).
PLANT SOURCES
Many fungi are phytopathogenic, with species such as Fusarium
spp.,Cladosporium spp.,Pythium spp.,Curvularia spp.,Aspergillus
ﬂavus, and Puccinia pittieriana affecting potato, rice, corn, wheat,
tobacco, and cotton crops by causing wilt, mold, crown rot,
mildew, and rust, just to name a few plant diseases (The Ameri-
can Phytopathological Society, APS4). These diseases can deplete
entire crops, bearing enormous costs for agriculture due to the
difﬁculty in eliminating fungal infections from plants, once they
appear. Soils harbor plants for most of their life cycle, but also
a considerable amount of bacteria, fungi, and parasites, many
of which can be phytopathogenic. For this reason, plants need
to have good defenses against these microorganisms; thus, it is
easy conceivable that plants are major AMPs producers, often
with antifungal activity, but also antibacterial activity (Moreno
et al., 1994; Segura et al., 1998; Thomma et al., 2002; Mayer et al.,
2013).
In fact, a major research effort has been put forward on the
screening for these molecules in plants. Besides defensins, other
AMPs are also produced by plants, being exclusive to them. Exam-
ples of these plant exclusive AMPs are thionins, lipid transfer
proteins and snakins, which were also demonstrated to have anti-
fungal activity (Segura et al., 1999; Silverstein et al., 2007; Sun
et al., 2008; Asano et al., 2013). Plant defensins with antifungal
activity have been puriﬁed from several plants, such as Pisum
sativum (Almeida et al., 2000; Lobo et al., 2007; de Medeiros,
2009; de Medeiros et al., 2010; Gonçalves et al., 2012b), Raphanus
sativus (Aerts et al., 2007, 2009; Tavares et al., 2008; Thevissen
et al., 2012), and Heuchera sanguinea (Thevissen et al., 1997; Aerts
et al., 2011), which will be addressed below. Several other plant
defensins with antifungal activity have also been studied. Speciﬁc
information about some of those defensins can be found on the
following references: Medicago sativa defensin 1 (MsDef1) and
Medicago truncatula defensin 4 (MtDef4; Spelbrink et al., 2004;
Ramamoorthy et al., 2007a,b; Sagaram et al., 2011); Dahlia mer-
ckii AMP 1 (DmAMP1; Thevissen et al., 1999, 2000a,b, 2003b; Jha
et al., 2009; Salahinejad et al., 2013); Phaseolus vulgaris defensin 1
(PvD1; Games et al., 2008; Mello et al., 2011; Wu et al., 2011; Chan
et al., 2012; Wong et al., 2012; Chan and Ng, 2013); Nicotiana alata
defensin 1 (NaD1; Lay et al., 2003, 2012; van der Weerden et al.,
2008, 2010; Hayes et al., 2013).
Psd1
This garden pea (Pisum sativum) seed defensin, ﬁrstly character-
ized in 2000 (Almeida et al., 2000), has 46 amino acid residues.
Its secondary structure comprises a globular fold composed of
β-sheets and an α-helix stabilized by four disulﬁde bridges, i.e.,
a cysteine-stabilized αβ-motif (Almeida et al., 2002). As demon-
strated by a yeast two-hybrid screening system, Psd1 has afﬁnity to
a Neurospora crassa protein related to the cell cycle control, cyclin
F (Lobo et al., 2007). Using a developing retinal tissue of neonatal
4http://www.apsnet.org/
rats as a model to study this interaction, it was proven that Psd1
impairs the correct cell cycle progression, by blocking cyclin F role
in the transition of S to G2 phases of the cell cycle, promoting
endoreduplication and disturbing nuclear migration. Recently, it
has been demonstrated through partition studies that Psd1 has a
high afﬁnity with high speciﬁcity to model membranes enriched
with ergosterol, the main sterol present in fungal membranes, and
GlcCer (Gonçalves et al., 2012b). On the contrary, there is no inter-
action between the defensin and model membranes enriched in
cholesterol (a characteristic of mammalian cells), reducing Psd1
toxicity to human cells.
RsAFP2
This defensin, isolated from radish (Raphanus sativus) seeds in
1992 (Terras et al., 1992), has 51 amino acid residues and is highly
cationic. It has eight cysteine residues, forming four disulﬁde
bridges that stabilize its αβ-motif structure. RsAFP2 has fungal
GlcCer as its target, as observed in experiments performed with
wild-type Candida albicans and a mutant lacking GlcCer in the
membrane (gcs; Aerts et al., 2007). It does not need to be inter-
nalized to have its antifungal effect. After the initial contact, a
signaling cascade is activated inside the cell and ROS are formed,
leading to membrane permeabilization and consequent cell death
(Aerts et al., 2007). Other effects of RsAFP2 comprise the induc-
tion of apoptosis in C. albicans by triggering caspases activation,
but not of metacaspases, implying that different apoptotic path-
ways can be induced in C. albicans (Aerts et al., 2009). RsAFP2
also promotes an accumulation of ceramides in C. albicans, which
can be lethal to the cell, and blocks the yeast-to-hypha transition
(Thevissen et al., 2012). In vivo experiments were performed in
murine models, proving that RsAFP2 considerably reduces the
fungal burden in kidneys of mice infected with C. albicans. This
defensin has low susceptibility to serum peptidases, meaning that
upon entering the bloodstream it will not be degraded, maintain-
ing its antifungal activity. Lactate dehydrogenase (LDH) release
levels are indicative of cell damage and tissue breakdown. Human
brain endothelial cells incubated with RsAFP2 show no release
of LDH, hence supporting the conclusion that this defensin has
limited toxicity to mammalian cells.
HsAFP1
Firstly identiﬁed in 1995, this defensin found in the seeds of coral
bells plant H. sanguinea (Osborn et al., 1995) was shown to have
high afﬁnity to speciﬁc sites in fungal membranes and to perme-
abilize cells of susceptible fungi (Thevissen et al., 1997). Unlike
RsAFP2, which relies on an interaction with GlcCer to exert its
antifungal effect, HsAFP1 has antifungal activity against C. albi-
cans gcs and its wild-type counterpart (Aerts et al., 2011). It was
proposed that HsAFP1 may interact with essential components of
the fungal membrane, resulting in a low occurrence of resistance
in vitro, an advantage for the use of HsAFP1 as a novel antifun-
gal agent (Aerts et al., 2011). Using sodium azide, a respiratory
inhibitor, mitochondrial function is impaired and HsAFP1 anti-
fungal activity is affected, indicating that the defensin requires a
properly working respiratory chain. This defensin induces ROS
formation and apoptosis in yeast. It was also proposed that
mitogen-activated protein kinase (MAPK) signaling pathwaysmay
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be a possible strategy for yeast tolerance to HsAFP1 (Aerts et al.,
2011).
ANIMAL SOURCES
Mammal defensins
Antimicrobial peptides from animal sources have shown antifun-
gal and immunomodulatory activities, being mammals major
producers of defensins (Yang et al., 2002a,b; Sahl et al., 2005).
θ-Defensins are the less studied defensin family, at least partially
due to their source. To date, no antifungal activity was attributed
to θ-defensins; as such, these defensins will not be further dis-
cussed in the present review. Being vertebrates, mammals possess
an adaptive immune system, hence having a more complex net-
work of signaling pathways, diverse responses against pathogens
invading the organism and an array of AMPs produced in different
organs and tissues, each with its particular function and mode of
action (Ganz and Lehrer, 1998; Ganz, 2004; Lai and Gallo, 2009;
Pasupuleti et al., 2012). Human β-defensins 1 and 2 are chemo-
tactic for memory T cells and immature dendritic cells (Pazgier
et al., 2006). Mammal defensins differ substantially in their antimi-
crobial speciﬁcities. For example, HNP-1, HNP-5 and human
beta-defensins 1 and 3 (HBD1 andHBD3, respectively) have broad
antimicrobial activities against Gram-negative and Gram-positive
bacteria and yeasts (Ganz et al., 1985; Bensch et al., 1995; Porter
et al., 1997;Harder et al., 2001;Hoover et al., 2003; Joly et al., 2004).
HBD1 and HBD3 have been shown to be effective against C. albi-
cans (Krishnakumari et al., 2009), while HBD2 has been shown
to possess signiﬁcant microbicidal activity against Gram-negative
bacteria and C. albicans (Schroder and Harder, 1999). Recombi-
nant human intestinal defensin 5 (rHD-5) exhibits microbicidal
activity against Listeria monocytogenes, Escherichia coli, and C.
albicans. Opposed to cryptdins, the mouse intestinal defensins,
rHD-5 is active against both mouse-virulent wild-type Salmonella
typhimurium and its isogenic, mouse-avirulent phoP mutant
(Porter et al., 1997).
Mouse β-defensin 3 (MBD3), a HBD2 homolog, is an
AMP expressed in the mouse epithelial and mucosal tissues
(Jiang et al., 2010). The fungicidal properties of recombinant
MBD3 suggest that similar peptide formulations can be used
in the treatment of fungal and/or bacterial infections. MBD3 is
expressed in footpads, skin, and mucosal membranes (tongue)
of normal mice. Potent antifungal activity was observed against
ﬁlamentous fungi, such as Aspergillus fumaricus, Microspo-
rum canis, Trichophyton rubrum, Trichophyton tonsurans, and
Trichophyton violaceum (all these species are primary human
pathogens, meaning they cause infection whether or not the
immune defenses are weakened, as opposed to opportunistic
fungal infections), as well as yeast strains like C. albicans and
Cryptococcus neoformans. This peptide also presents bacterici-
dal activity against Gram-positive and Gram-negative bacteria,
such as Staphylococcus aureus, E. coli, and Salmonella typhi
(Jiang et al., 2010).
Arthropods defensins
Coprisin. This 43 amino acid residues beetle defensin-like pep-
tide was described in 2009 as an antibacterial peptide (Hwang
et al., 2009). Its structure comprises an αβ-motif, stabilized by
three cysteine disulﬁde bridges (Lee et al., 2013). In 2012, the
same authors investigated its antifungal activity against C. albi-
cans, revealing that coprisin enters the fungal cell and localizes
in the nucleus, which indicates that coprisin penetrated the
membrane without disrupting the fungal plasma membrane, as
conﬁrmed with 1,6-diphenyl-1,3,5-hexatriene (DPH) analysis,
calcein-leakage, and giant unilamellar vesicle assays (Lee et al.,
2012). Using H2O2 as a positive control for apoptotic induction,
coprisin proved to have the same effects in inducing early and
late apoptosis, features shown by the annexin V conjugated with
ﬂuorescein and propidium iodide co-staining method. Apoptosis
induced by this AMP is metacaspase-dependent. Concomitantly,
coprisin compromises mitochondrial membrane potential and
ROS production, in addition to the release of cytochrome c
from the mitochondria to the cytosol. No hemolytic activity was
observed for this peptide in human erythrocytes (Lee et al., 2012).
Juruin. This defensin-like peptide was discovered in 2012 by
screening the venom on the theraposid Amazonian pink toe spi-
der Avicularia juruensis (Ayroza et al., 2012). It has 38 amino acid
residues, three disulﬁde bonds and, like neurotoxins reported to
have antimicrobial activity, it has a putative inhibitory cysteine
knot (ICK) motif, i.e., a fold common to venom peptides from
spiders, scorpions, and aquatic cone snails (Smith et al., 2011).
ICK-containing peptides of spider venomare likely to have evolved
from β-defensins (Fry et al., 2009). Based on amino acid sequence
and structure similarities with insecticidal peptides of other spi-
ders, this peptide is likely to belong to a group of conserved toxins
with voltage-gated ion channels inhibitory action. Juruin showed
a fungicidal rather than fungistatic effect against C. albicans and
C. tropicalis, without hemolytic activity (Fry et al., 2009).
Reptile defensins
Crotamine. This highly basic peptide, isolated from the venom of
a South-American rattlesnake, was discovered in 1947 (Gonçalves
and Polson, 1947). It shares structural similarity to β-defensins
due to an identical disulﬁde bridge pattern (Fadel et al., 2005;
Yamane et al., 2013). Crotamine structure comprises an antipar-
allel β-sheet and an α-helix stabilized by three disulﬁde bridges
(Nicastro et al., 2003; Fadel et al., 2005). Recombinant crotamine
displayed a more potent antimicrobial activity than native and
synthesized crotamine (Yamane et al., 2013). This peptide induces
extensive ultrastructural modiﬁcations in C. albicans. TEM stud-
ies showed deformed cell shape, irregular layering structure of cell
wall and cytoplasmic contents coagulation, but without detectable
hemolytic effects and low toxicity to mammalian cells (Yamane
et al., 2013).
IMMUNOMODULATORY FUNCTION
Defensins may be produced constitutively or have their expres-
sion triggered when there is an inﬂammatory process, by the
recognitionof microbial conserved structures, such as lipopolysac-
charide (LPS) and lipoteichoic acid, or inﬂammatory effectors,
like cytokines. These AMPs are expressed differentially depend-
ing on the peptide itself and on the tissue or cell type (Ulm
et al., 2012). Defensins, besides their antimicrobial action, can
also be immunomodulatory and inhibitors of virulence factors.
This ability is not exclusive of defensins, as other AMPs also
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share this property. Thus, they can enhance the host’s immune
system, with this multifunctional character rendering these pep-
tides lower probability of becoming tolerated by microorganisms
(Mehra et al., 2012; Jarczak et al., 2013).
Pro-inﬂammatory mediation has been recognized in some
of these molecules, as they can bind to chemokine receptors,
being able to recruit immune cells, thus enhancing the immune
response (Mookherjee and Hancock, 2007; Lai and Gallo, 2009;
Alba et al., 2012; Semple and Dorin, 2012; Ulm et al., 2012;
Zhu and Gao, 2013). β-Defensins were demonstrated to have
the capability to induce chemoattraction of CD4+ memory T
cells, macrophages, and immature dendritic cells, by binding to
receptors in the membrane (Yang et al., 1999; Wu et al., 2003;
Taylor et al., 2008). This binding favors the attraction and migra-
tion of inﬂammatory cells to the inﬂammation site, in order
to improve and speed up the inﬂammatory response. α and β-
Defensins have also been shown to inhibit neutrophil apoptosis
(Nagaoka et al., 2008). These authors showed that HBD3 binds
to CCR6 at the neutrophil cell surface, initiating an increase
in the levels of the antiapoptotic protein Bcl-xL and inhibit-
ing caspase activity. This increases neutrophils life span and is
an inﬂammatory event that is beneﬁcial to eradicate invading
microorganisms (Nagaoka et al., 2008), thus promoting the pro-
duction of proinﬂammatory cytokines and chemokines, which in
turn, ampliﬁes the immune system response. Defensins have been
shown to have a proinﬂammatory effect on human keratinocytes
(Niyonsaba et al., 2007). Treatment of these cells with HBD2
HBD3 or HBD4 leads to the increase of the expression of pro-
inﬂammatory mediators, like monocyte chemoattractant protein-
1, macrophage inﬂammatory protein-3, and some interleukins
(Niyonsaba et al., 2007).
Surprisingly, some defensins are also able to attenuate pro-
inﬂammatory responses whenever these can be harmful to the
organism (Lande et al., 2007; Yamasaki et al., 2007). These
antagonistic effects depend on the level of expression, dis-
ease state, and pathogen exposure. It has been previously
described for α-defensins that mice having a matrilysin deﬁ-
ciency (hence without mature α-defensins in the intestine) are
more susceptible to chemically induced colitis than wild-type
controls. Interleukin-1β (IL-1β), a cytokine with an important
role in mediation of inﬂammation, reaches level signiﬁcantly
increased in the deﬁcient mice and it was ultimately shown
that α-defensins are able to inhibit the production of IL-1β
(Shi et al., 2007).
It has been demonstrated that HBD3 (mainly expressed in
epithelial cells), when in basal concentration, has an immuno-
suppressive effect in the presence of LPS, contributing to the
maintenance of a non-inﬂammatory environment over continual
low-level exposure to microorganisms, commensal or pathogenic
(Semple et al., 2010). Concentrations of HBD3 ranging from0.5 to
1 μM are able to suppress the induction of tumor necrosis factor
α (TNFα), a proinﬂammatory effector of the immune system, and
IL-6, an interleukin that acts both as pro and anti-inﬂammatory. At
these concentrations, proinﬂammatory proteins are not induced
and there is no proinﬂammatory gene expression (Semple et al.,
2010). The proinﬂammatory effects of β-defensins were observed
at slightly higher concentrations of the defensin, in the 4–6 μM
range (Funderburg et al., 2007; Niyonsaba et al., 2010). This was
not the ﬁrst case observed of opposite effects in immunomodu-
lating AMPs. Cathelicidin LL-37 has been shown to have also a
duality in inﬂammatory effects, being proinﬂammatory at con-
centrations above 20 μg/ml but anti-inﬂammatory at 1–5 μg/ml
(Scott et al., 2002). Defensins were also shown to have a role in
other biological processes, namely wound healing (Hirsch et al.,
2009), dog coat color determination (Candille et al., 2007), fer-
tility (Li et al., 2001), plant development (Stotz et al., 2009), and
carcinogenesis regulation (Donald et al., 2003; Gambichler et al.,
2006; Joly et al., 2009).
It is clear that defensins have many functions that are
determined by the level of expression. Whereas higher expres-
sion of defensins takes place at the pathogen’s site of entry,
with a proinﬂammatory response and the chemoattraction of
macrophages and other immune cells, defensins expressed at
lower levels may be involved in the resolution of the immune
response. When the danger is neutralized and defensins and
other proinﬂammatory molecules decrease in the inﬂammation
site, defensins may then have a role in resolving inﬂammation
(Semple and Dorin, 2012).
Due to this multifunctionality, AMPs have also been referred
to as host defense peptides (HDPs; Steinstraesser et al., 2010; Ulm
et al., 2012).
RESISTANCE
Like other antibiotics resistance, it is easily conceivable that
AMPs resistance is a key characteristic for increased virulence
of pathogenic strains. Despite this fact, and contrary to antibi-
otics that act through a single approach (meaning that microbes
can evade them through a single resistance system), AMPs fol-
low a multidimensional strategy against microbial invasion (Lai
and Gallo, 2009). Therefore, selective pressures on microbes are
avoided, reducing the development of resistant strains (Zasloff,
2002).
A synergistic effect between different hostAMPs is also possible,
as evidenced by the fact that the MIC of AMPs in vitro are usually
higher than the physiological concentrations of thoseAMPs in vivo
(Lai andGallo,2009). TwodistinctAMPsmayhave their combined
MIC much lower than when acting isolated, strongly suggesting
heterologous HDP interactions (Westerhoff et al., 1995).
Microorganisms have evolved their own strategies for evading
the antimicrobial action of the compounds used against them.
AMPs frequently have the ability to disrupt microbial membranes
and to inhibit the synthesis of some of their components; thus,
strategies to escape the action of thoseAMPs follow the redesign of
cell membranes, as described for both Gram-negative and Gram-
positive bacteria (Gunn et al., 2000; Li et al., 2007). Other evasion
mechanisms include affecting the correct function of the AMP
by turning off its expression, releasing plasmid DNA in epithe-
lial cells, a strategy adopted by highly contagious bacteria from
the Shigella genus that cause dysentery (Islam et al., 2001). As
AMPs frequently rely on transmembrane potential to interact with
microbial pathogens and exert their mechanism of action against
them, it is probable that another microbe strategy for evading
AMPs could be to change their transmembrane potential status
(Yeaman and Yount, 2003).
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Candida albicans resistance to some AMPs is regulated by
the protein Ssd1, combined with the transcription factor Bcr1
(bioﬁlm and cell wall regulator; Nobile and Mitchell, 2005; Gank
et al., 2008; Jung et al., 2013). Ssd1 is an RNA-binding protein
and a component of the regulation of morphogenesis pathway
(Saputo et al., 2012). In C. albicans, this pathway governs mul-
tiple processes, including ﬁlamentation and cell wall integrity
(Song et al., 2008; Bharucha et al., 2011). This combination yields
resistance to protamine, RP-1 and HBD2 by maintaining mito-
chondrial energetics and reducing membrane permeabilization,
thus allowing the fungus to counteract the negative effects of
these AMPs (Jung et al., 2013). Protamine is an α-helical cationic
polypeptide, frequently used to screen forAMP susceptibility (Yea-
man et al., 1996), and RP-1 is a synthetic AMP modeled upon
the C-terminal α-helical domain existent in the human platelet
factor-4 kinocidins; this domain is responsible for RP-1 microbi-
cidal activity (Bourbigot et al., 2009). C. albicans mutant strains
in Bcr1 and Ssd1 proteins are more susceptible to the AMPs
described above; thus, Jung et al. (2013) were able to conclude
that these proteins are necessary for the resistance to protamine,
RP-1 and HBD2. Further studies are necessary to clarify the roles
of Bcr1 and Ssd1 in early versus late mechanisms of resistance to
AMPs.
The Hog1 (high osmolarity glycerol) MAPK pathway, which
provides a response to osmotic, oxidative, and heavy-metal expo-
sure stresses in fungal cells, was shown to be activated in the
presence of AMPs, such as NaD1, HBD2, HBD3, and histatin-5 (a
salivary cationic AMP that has a role in keeping C. albicans in its
commensal state;Yeamanet al.,1996;Vylkova et al.,2007;Argimon
et al., 2011; Hayes et al., 2013). The injuries imposed on C. albicans
by these defensins seem to share common features with osmotic
and/or oxidative stress (Argimon et al., 2011). Upon exposure to
these defensins, the Hog1 MAP kinase is activated, triggering a
transcriptional response aimed to rescue the cells from the source
of injury, i.e., the core andosmotic-stress transcriptional responses
(Enjalbert et al., 2006; Argimon et al., 2011).
Another strategy for evading AMP function is to enzymati-
cally degrade these peptides before they exert their effects. This is
possible by producing proteases and peptidases involved in tissue
degradation, as described for C. albicans secreted aspartic pro-
teases (Saps). Namely, histatin-5, present in human saliva, is a
host-speciﬁc substrate of Sap9, enabling the transition of the fun-
gus from commensal to pathogenic in HIV+ individuals. These
patients, who have lower levels of this isoenzyme in the saliva,
have an increased incidence of oral candidiasis (Meiller et al., 2009;
Khan et al., 2013). Also regarding histatin-5, a transport mecha-
nismof efﬂuxmediated by the ﬂu-1 transporter has beendescribed
for C. albicans, rendering the pathogen the ability to reduce the
isoenzyme cytosolic concentration and fungicidal activity (Li et al.,
2013). The LL-37 cathelicidin and histatins bind to cell wall carbo-
hydrates, preventing adhesion of C. albicans to host cells; thus, the
release of AMP-binding proteins acts as a decoy for these AMPs,
diverting them from binding to fungal cell surface (den Hertog
et al., 2005, 2006; Mochon and Liu, 2008). For example, Msb2
(multicopy suppressor of a budding defect) is a C. albicans sur-
face protein (a mucin) highly soluble and proteolytically stable,
which is shed to the extracellular environment, acting as a basal
AMP-resistance decoy by binding to LL-37 and histatin-5, avoid-
ing the antimicrobial action of these AMPs (Szafranski-Schneider
et al., 2012).
The characteristics described above are associated with a
decrease in microbes’ susceptibility to AMPs, indicating that
microbial pathogens have developed some structure-speciﬁc and
energy-dependent mechanisms to subvert the action of these host
defense systems.
FUNGAL CELL MEMBRANE
Fungi possess a unique cell wall and cell membrane that can serve
as speciﬁc targets for antifungal agents. The fungal cell membrane
is similar to those of other eukaryotic cells, composed of a lipid
bilayer with proteins embedded within it (Katzung et al., 2011).
Sterols (absent in prokaryotes) are major components of fungal
membranes. The sterol present in higher eukaryotic membranes
is cholesterol, but in fungal membranes the main sterol present is
ergosterol, providing stability and ﬂexibility to the cell membrane
(Thevissen et al., 1999, 2003a).
Glycosphingolipids (GSLs) are a family of lipids that act as
key components of biological membranes. They exist in animals,
plants, and fungi (Leipelt et al., 2001; Halter et al., 2007; Daniotti
and Iglesias-Bartolome, 2011). GSLs were initially described as
components of the architecture of cell membranes, straightly con-
nected with ﬂuidity and stability (Feinstein et al., 1975; Aaronson
and Martin, 1983; Campanella, 1992). Recently, however, it was
demonstrated that their role goes clearly beyond the initial con-
cept, since these molecules are major components of specialized
membrane domains called lipid rafts (Bagnat et al., 2001; Hako-
mori, 2003, 2008). GSLs have been characterized as important
structures in cell–cell interaction, cell signaling, and protein sort-
ing (Bagnat et al., 2000; Bagnat and Simons, 2002; Nimrichter
et al., 2008; Staubach and Hanisch, 2011). Lipid rafts are more
ordered and tightly packed than the surrounding bilayer, serv-
ing as organizing centers for the assembly of signaling molecules,
inﬂuencing membrane ﬂuidity and membrane protein trafﬁcking
(Chiantia and London, 2013).
The most common GSL found in fungi is GlcCer, present in
the membranes of most fungi, such as Pichia pastoris, C. albi-
cans, Cryptococcus neoformans, Aspergillus fumigatus, Sporothrix
schenckii and Neurospora crassa (Saito et al., 2006). Large amounts
of this GSL have also been found in the fungal cell wall (Nim-
richter and Rodrigues, 2011). GlcCer has been identiﬁed as
a fungal component decades ago. Its functions during fun-
gal growth/dimorphism, lipid raft formation, and correlation
with virulence have been reported (Rittershaus et al., 2006).
In fact, it was recently shown to be required for virulence
in C. albicans (de Medeiros et al., 2010; Noble et al., 2010;
de Coninck et al., 2013).
Work published by Thevissen and colleagues strongly suggested
that fungal GlcCer targeting by the AMPs RsAFP2 and HsAFP1
could initiate a cell signaling response in fungi, with formation
of ROS and subsequent cell death by apoptosis (Thevissen et al.,
2004; Aerts et al., 2007, 2009, 2011). The use of anti-GlcCer anti-
bodies was shown to block germ tube formation in C. albicans,
Colletotrichum gloeosporioides, and Pseudallescheria boydii (Pinto
et al., 2002; da Silva et al., 2004), and also to protect mice upon
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the potentially lethal infection by C. neoformans (Rodrigues et al.,
2007).
The crescent knowledge of GlcCer functions in eukaryotes
(may these be related to virulence, growth or morphological
transitions), together with the ﬁndings described above, can be
connected to speciﬁc and essential structural features and partic-
ular biosynthetic steps to validate this GSL, as well as other fungal
speciﬁc membrane lipids and sterols, as potential targets on the
development and discovery of new antifungal drugs (Nimrichter
and Rodrigues, 2011; Gonçalves et al., 2012b). Besides GlcCer,
fungal membranes are also rich in phosphomannans and in the
negatively charged phospholipids PS, phosphatidylinositol (PI)
and diphosphatidylglycerol (DPG),which confer a highly negative
surface charge to these membranes (Pasupuleti et al., 2012).
MODELS OF MEMBRANE ACTIVITY – MECHANISM OF
ACTION
The biological activity of AMPs is strongly inﬂuenced by peptide–
membrane interactions. To explain how some AMPs show differ-
ential membrane afﬁnity, their biological activities, and modes
of action have been assessed on studies of defensins interac-
tion with fungal membrane model systems, which showed a
strong dependence on membrane lipid composition and on
the concentration of speciﬁc components (de Medeiros et al.,
2010; Gonçalves et al., 2012a,b). As with other AMPs, the
mechanisms of action of some plant defensins with antifun-
gal activity involve membrane binding, binding to the cell wall,
interaction with intracellular targets leading to apoptosis, mem-
brane permeabilization, and receptor-mediated internalization
(van der Weerden et al., 2013).
The mechanisms of action of some defensins have been studied
by using synthetic lipid vesicles mimicking the lipid composition
of fungal, bacterial and mammal membranes (de Medeiros et al.,
2010; Wimley and Hristova, 2011; Gonçalves et al., 2012a,b). The
permeabilization models used to explain the mode of action of
defensins could be classiﬁed into two main groups: transmem-
branepore formation, such as the barrel-stave and toroidalmodels,
and non-pore formation, such as the carpet, aggregate channel,
Shai–Matsuzaki–Huang, lipid clustering, and interfacial activity
models (Alba et al., 2012). The carpet model can evolve to dis-
rupt the membrane through pore formation models or through a
detergent-like mechanism, with partial micellization of the mem-
brane (Bechinger and Lohner, 2006; Chang et al., 2008; Hoskin
and Ramamoorthy, 2008). There are currently at least three differ-
ent commonly accepted models describing possible AMPs mode
of action: the barrel-stave pore model, the toroidal pore model,
and the carpet model (Shai, 2002; Chang et al., 2008; Hoskin and
Ramamoorthy, 2008; Alba et al., 2012).
Most defensins are amphipathic molecules with clusters of pos-
itively charged amino acid residues side chains and hydrophobic
amino acid side chains (Lehrer and Lu, 2011). This structural
behavior allows them to interact with microbial membranes both
at the level of the negatively charged phospholipid head groups
and of the hydrophobic fatty acid chains. The orientation of the
peptide on themembrane surface depends on the speciﬁc peptide–
lipid system, but it is common for theAMP to stay at themembrane
interface until a threshold peptide concentration is reached (Yang
et al., 2000; Yount and Yeaman, 2005; Pasupuleti et al., 2012). In
the barrel-stave model (Figure 2), once the critical threshold con-
centration of peptide is reached, peptides self-aggregate in the
membrane resulting in the formation of a transmembrane pore
lined by peptide, which dissipates proton and ionic gradients
(Ehrenstein and Lecar, 1977; Reddy et al., 2004), but the mem-
brane thickness and homogeneity do not change (Chang et al.,
2008). The toroidal pore model is a variant of the barrel-stave
model, claiming that, at some critical peptide concentration, cur-
vature strain induces membranes to curve inward, resulting in
the formation of a pore that is lined by both peptides and lipid
headgroups (Figure 2). Toroidal pores seem to have varying life-
times and longer-lived pores may have a lethal effect similar to
barrel-stave pores, with dissipation of proton and ion gradients.
This type of mechanism of AMPs action also causes a decrease in
membrane thickness and a slightly decreased surface homogene-
ity (Chang et al., 2008). In the carpet model (Figure 2), peptides
bind to phospholipid head groups by electrostatic interactions and
align themselves parallel to the membrane surface in a carpet-like
fashion until a critical threshold concentration is reached. When
a detergent-like membrane micellization takes place, a strong
decrease of membrane homogeneity occurs (Chang et al., 2008;
Hoskin and Ramamoorthy, 2008; Epand et al., 2010; Hazlett and
Wu, 2011; Li et al., 2012; Pasupuleti et al., 2012).
Besides targeting fungal membranes’ speciﬁc components,
defensins may also have other mechanisms of action, as previ-
ously referred. These mechanisms comprise binding to the cell
wall, membrane permeabilization, receptor-mediated internaliza-
tion inducing signaling cascades and interaction with intracellular
targets, which would cause the formation of ROS, leading ulti-
mately to programed cell death. To address these mechanisms the
reader is directed to some relevant references on this topic (Han-
cock and Rozek, 2002; Oberparleiter et al., 2003; Thevissen et al.,
2003a, 2004; Schroeder et al., 2011; de Coninck et al., 2013; De
FIGURE 2 | Models of lipid membrane permeabilization by AMPs.
Initially, the peptide (magenta) is adsorbed at the membrane surface. After
an initial recognition of the surface, a conformational change of the peptide
occurs. Once a threshold concentration of peptide on the membrane is
reached, it is followed by membrane disruption by one of these three
mechanisms.
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Paula et al., 2013; Jaeger et al., 2013; van der Weerden et al., 2013;
Zhang et al., 2013).
CONCLUSION
The knowledge on AMPs has been increasing considerably during
the last 20 years. This increased knowledge shows that AMPs have
much more than only antimicrobial activity, presenting a broad
spectrum of physiological functions. Defensins are the most rep-
resented AMPs across the eukaryotic domain, and in all types
of eukaryotic organisms we can ﬁnd defensins not only with
antifungal activity but also with other potential applications.
Despite this relevance, defensins may have limitations in terms
of new drug development, due to their cationic, amphiphilic, and
protease labile nature, leading to a low serum half-life that limits
their systemic administration (Maisetta et al., 2008). This limi-
tation can be overcome by the use of peptidomimetics, like the
substitution of natural occurring L-amino acid residues by D-
amino acid residues or unusual amino acids (Oren et al., 1997;
McPhee et al., 2005). Defensins bare a favorable characteristic
against this problem, as their disulﬁde-stabilized structure con-
fers increased protease-resistance (Wu et al., 2003). Nonetheless,
defensins combine targeted antimicrobial activity with the capac-
ity to positively modulate the immune system, and have proven
to be effective across life evolution, making these peptides highly
appealing as an anti-infective strategy.
Defensins have evolved as successful barrier of defense not
only against bacteria, but also pathogenic fungi, present among
plants, animals, and fungi. This ability may serve as a “lesson”
on how selective pressures that shape organisms and their com-
ponents served and continue to serve as a lever for the evolution
of better defenses. Most antibiotics used nowadays are from bac-
terial origin or synthetic (Clardy et al., 2009; Fisher et al., 2012).
The molecular design and synthesis of new molecules inspired
on defensins or on other AMP structures and sequences seem to
be a promising approach to develop a new and extensive ﬁeld of
applications, ranging from antimicrobial therapy, to their possi-
ble use as vaccine adjuvants. Therefore, a better understanding of
function and mechanism of action of HDPs, specially defensins,
is highly relevant for the development of new anti-infective and
immunomodulatory therapeutics (Guaní-Guerra et al., 2013).
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